Marquette Asset Management »

Aclaris Therapeutics shares owned by Marquette Asset Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Marquette Asset Management from 13F filings

Historical chart of Marquette Asset Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Marquette Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Marquette Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $104k 84k 1.24

More positions owned by Marquette Asset Management

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Schwab Strategic Tr Us Dividend Eq (SCHD)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Mid Cap Etf (VO)
Victory Portfolios Ii Short Trm Bd Etf (USTB)
Spdr Ser Tr S&p Kensho New (KOMP)
Invesco Exchange Traded Fd T S&p500 Pur Gwt (RPG)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Ishares Tr Rus 1000 Val Etf (IWD)
First Tr Dow Jones Select Mi Com Shs Annual (FDM)

View all positions for Marquette Asset Management

Top funds holding Aclaris Therapeutics

BML Capital Management
BlackRock
Vanguard Group
D. E. Shaw & Co
Millennium Management
Bain Capital Life Sciences Investors
Rock Springs Capital Management
Acadian Asset Management
Geode Capital Management
Two Sigma Advisers
Two Sigma Investments
Qube Research & Technologies
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Samsara BioCapital

View all funds holding Aclaris Therapeutics